Dose adjustment of phenytoin for comedication in Japanese patients with epilepsy

Therapeutic Drug Monitoring

Volumn 31, Issue 1, 2009, Pages 57-62

  Fukuoka, Noriyasu ^a   Uno, Junji ^b   Tsukamoto, Toyohisa ^c   Houchi, Hitoshi ^a   Kimura, Michio ^d   Morita, Shushi ^c  

^a KAGAWA UNIVERSITY HOSPITAL   (Japan)

^b Okehazama Hospital   (Japan)

^c HIROSHIMA INTERNATIONAL UNIVERSITY   (Japan)

^d YASUDA WOMEN'S UNIVERSITY   (Japan)

Author keywords

Extracellular water volume; Michaelis Menten model; Phenytoin; Therapeutic drug monitoring; Transforming factor

Indexed keywords

CARBAMAZEPINE; CLONAZEPAM; ETHOSUXIMIDE; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID; ZONISAMIDE;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BODY SURFACE; BODY WATER; BODY WEIGHT; CHILD; CONTROLLED STUDY; DOSE CALCULATION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG MONITORING; EPILEPSY; FEMALE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; MICHAELIS MENTEN KINETICS; MONOTHERAPY; MORNING DOSAGE; PRIORITY JOURNAL;

ADULT; AGED; AGING; ALGORITHMS; ANTICONVULSANTS; BODY SURFACE AREA; BODY WATER; BODY WEIGHT; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; EPILEPSY; EXTRACELLULAR FLUID; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; HUMANS; JAPAN; MALE; MIDDLE AGED; MODELS, STATISTICAL; PHENYTOIN; REGRESSION ANALYSIS; SEX CHARACTERISTICS;

EID: 60449093421     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/FTD.0b013e3181947772     Document Type: Article

References (28)

1. Perucca E. Patient-tailored antiepileptic drug therapy: predicting response to antiepileptic drugs. Int Congr Ser. 2002;1244:93-103.
2. Pellock JM. Treatment considerations: traditional antiepileptic drugs. Epilepsy Behav. 2002;3:S18-S23.
3. Patsalos PN, Fröscher W, Pisai F, et al. The importance of drug interactions in epilepsy therapy. Epilepsia. 2002;43:365-385.
4. Parker BM, Cusack BJ, Vestal RE. Pharmacokinetic optimization of drug therapy in elderly patients. Drugs Aging. 1995;7:10-18.
5. Battino D, Croci D, Mamoli D, et al. Influence of aging on serum phenytoin concentrations: a pharmacokinetic analysis based on therapeutic drug monitoring data. Epilepsy Res. 2004;59:155-165.
6. Hayes MJ, Langman MJ, Short AH. Changes in drug metabolism with increasing age: 2 phenytoin clearance and protein binding. Br J Clin Pharmacol. 1975;2:73-79.
7. Odani A, Hashimoto Y, Takayanagi K, et al. Population pharmacokinetics of phenytoin in Japanese patients with epilepsy: analysis with a dose-dependent clearance model. Biol Pharm Bull. 1996;19:444-448.
8. Zielinski JJ, Haidukewych D, Leheta BJ. Carbamazepine-phenytoin interaction: elevation of plasma phenytoin concentrations due to carbamazepine comedication. Ther Drug Monit. 1985;7:51-53.
9. Mullen PW, Foster RW. Comparative evaluation of six techniques for determining the Michaelis-Menten parameters relating phenytoin dose and steady-state serum concentrations. J Pharm Pharmacol. 1979;31: 100-104.
10. Friis-Hansen B. Body water compartments in children: changes during growth and related changes in body composition. Pediatrics. 1961;28: 169-181.
11. Fujimoto S, Watanabe T, Sakamoto A, et al. Studies on the physical surface area of Japanese part 18 calculation formulas in three stages over all age. Jap J Hyg. 1968;23:443-450.
12. Bachmann KA, Belloto RJ Jr. Differential kinetics of phenytoin in elderly patients. Drugs Aging. 1999;15:235-250.
13. Perucca E, Berlowitz D, Birnbaum A, et al. Pharmacological and clinical aspects of antiepileptic drug use in the elderly. Epilepsy Res. 2006;68S: S49-S63.
14. Perucca E. Influence of aging on serum phenytoin concentrations: a pharmacokinetic analysis based on therapeutic drug monitoring data. Epilepsy Res. 2004;59:155-165.
15. Battino D, Estienne M, Avanzini G. Clinical pharmacokinetics of antiepileptic drugs in paediatric patients. Part II. Phenytoin, carbamaze-pine, sulthiame, lamotrigine, oxcarbamazepine and felbamate. Clin Pharmacokinet. 1995;29:341-369.
16. Yukawa E, To H, Ohdo S, et al. Population-based investigation of valproic acid relative clearance using nonlinear mixed effects modeling: influence of drug-drug interaction and patient characteristics. J Clin Pharmacol. 1997;37:1160-1167.
17. Perucca E. Pharmacokinetic variability of new antiepileptic drugs at different ages. Ther Drug Monit. 2005;27:714-717.
18. Perucca E. Age-related changes in pharmacokinetics: predictability and assessment methods. Int Rev Neurobiol. 2007;81:183-199.
19. Perucca E. Clinical pharmacokinetics of new-generation antiepileptic drags at the extremes of age. Clin Pharmacokinet. 2006;45:351-363.
20. Hori R, Okumura K, Kitazawa S, et al. Estimation of population pharmacokinetic parameters in Japanese patients. III. Phenytoin. Yakuzaigaku. 1990;50:292-299.
21. Yukawa E, Hokazono T, Satou M, et al. Pharmacokinetic interactions among phenobarbital, carbamazepine and valproic acid in pediatric Japanese patients: clinical considerations on steady-state serum concentration-dose ratios. Am J Ther. 2000;7:303-308.
22. Milsap RL, Szefler SJ. Special pharmacokinetic considerations in children. In: Evans WE, Schentag JJ, Jusko WJ, eds. Applied Pharmacokinetics. 2nd ed. Spokane, WA: Applied Therapeutics Inc; 1986:294-330.
23. Battles H. Drug therapy in childhood: what has been done and what has to be done? Pediatr Pharmacol (New York). 1983;3:131-143.
24. Riva R, Albani F, Contin M, et al. Pharmacokinetic interactions between antiepileptic drugs. Clin Pharmacokinet. 1996;31:470-493.
25. Patosalos PN, Perucca E. Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs. Lancet Neurol. 2003;2:347-356.
26. Kimura M, Ieiri I, Mamiya K, et al. Genetic polymorphism of cytochrome P450s, CYP2C19, and CYP2C9 in a Japanese population. Ther Drug Monit. 1998;20:243-247.
27. Odani A, Hashimoto Y, Otsuki Y, et al. Genetic polymorphism of the CYP2C subfamily and its effect on the pharmacokinetics of phenytoin in Japanese patients with epilepsy. Clin Pharmacol Ther. 1997;62:287-292.
28. Mamiya K, Ieiri I, Shimamoto J, et al. The effects of genetic polymorphism of CYP2C9 and CYP2C19 on phenytoin metabolism in Japanese adult patients with epilepsy: studies in stereoselective hydroxylation and population pharmacokinetics. Epilepsia. 1998;39:1317-1323.